Depression. This block contains disorders in which the fundamental disturbance is a change in affect or mood to depression (with or without associated anxiety) or to elation. The mood change is usually accompanied by a change in the overall level of activity
Conditions
Interventions
Intervention 1: The intervention group included 30 depressed patients with hypo magnesiumia will give daily two tablets of magnesium oxide. They will take tablets after breakfast and after dinner for
Treatment - Drugs
Placebo
The intervention group included 30 depressed patients with hypo magnesiumia will give daily two tablets of magnesium oxide. They will take tablets after breakfast and after dinner for 8 weeks.
afte
The control group nclude of 30 depressed patients with hypo magnesium daily two tablets of placebo in terms of shape and color appearance similar to the magnesium tablet are a number after breakfast
Sponsors
Research Council (Research and Technology) of Shahid Sadooghi University of Medical Sciences and Hea
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: people aged 20-60 years old and depression is diagnosed by a psychiatrist; not suffering from disorders and diseases of the kidney, liver, heart, thyroid, bleeding disorders and malignancies; non- degenerative disease autoimmune; non- autoimmune degenerative diseases; lack of central nervous system diseases; no history of mental illness; lack of food; lack of consumption of antidepressants and diuretics during the last 3 months pregnant and not lactating and non- events include loss of job; divorce; death of first-degree relatives in the past 3 months and have not participated in other research projects that self -reporting of this information will be recorded. Exclusion criteria: people who are not more than 20 % of the drug; while studying people who start taking a multivitamin and mineral supplement may have changed who have created the drug are.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression. Timepoint: Before the intervention, and three months after intervention. Method of measurement: Beck Depression Inventory.;Serum magnesium. Timepoint: Three months after the intervention, but intervention. Method of measurement: Serum magnesium test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Diarrhea. Timepoint: Monthly. Method of measurement: Ask the patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactProf. Hassan Mozaffari Khosravi
Shahid Sadooghi University of Medical Sciences and Health Services in Yazd
Outcome results
None listed